|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
ISO |
N'-nitrosonornicotine results in increased expression of BCL2 mRNA Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA] |
CTD |
PMID:16582591 PMID:16835749 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
affects binding |
ISO |
N'-nitrosonornicotine binds to CHRNA3 protein |
CTD |
PMID:16835749 PMID:18385738 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
affects binding |
ISO |
N'-nitrosonornicotine binds to CHRNA5 protein |
CTD |
PMID:18385738 |
|
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
affects binding |
ISO |
N'-nitrosonornicotine binds to CHRNB4 protein |
CTD |
PMID:18385738 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
CYP1A1 protein affects the metabolism of and results in increased activity of N'-nitrosonornicotine |
CTD |
PMID:11774366 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases metabolic processing increases hydroxylation multiple interactions |
ISO |
CYP2A13 protein results in increased metabolism of N'-nitrosonornicotine CYP2A13 protein results in increased hydroxylation of N'-nitrosonornicotine [CYP2A13 protein results in increased metabolism of N'-nitrosonornicotine] which results in increased abundance of 4-hydroxy-1-(3-pyridyl)-1-butanone; [CYP2A13 protein results in increased metabolism of N'-nitrosonornicotine] which results in increased abundance of 4-hydroxy-4-(3-pyridyl)butanoic acid; [CYP2A13 protein results in increased metabolism of N'-nitrosonornicotine] which results in increased abundance of 4-oxo-4-(3-pyridinebutanal); N'-nitrosoanabasine inhibits the reaction [[CYP2A13 protein results in increased metabolism of N'-nitrosonornicotine] which results in increased abundance of 4-hydroxy-1-(3-pyridyl)-1-butanone]; N'-nitrosoanatabine inhibits the reaction [[CYP2A13 protein results in increased metabolism of N'-nitrosonornicotine] which results in increased abundance of 4-hydroxy-1-(3-pyridyl)-1-butanone]; Nicotine inhibits the reaction [[CYP2A13 protein results in increased metabolism of N'-nitrosonornicotine] which results in increased abundance of 4-hydroxy-1-(3-pyridyl)-1-butanone] |
CTD |
PMID:17922361 PMID:27567546 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of N'-nitrosonornicotine |
CTD |
PMID:32672941 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Gata3 |
GATA binding protein 3 |
multiple interactions increases activity increases expression |
ISO |
Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased activity of GATA3 protein]; Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased expression of GATA3 mRNA]; Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased activity of GATA3 protein]; Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of GATA3 mRNA] |
CTD |
PMID:16582591 PMID:16835749 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases expression |
ISO |
Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased expression of NFKB1 mRNA]; Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of NFKB1 mRNA] |
CTD |
PMID:16582591 PMID:16835749 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions increases expression |
ISO |
Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of PCNA mRNA] |
CTD |
PMID:16582591 PMID:16835749 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
increases expression |
EXP |
N'-nitrosonornicotine results in increased expression of PLA2G2A mRNA |
CTD |
PMID:24835565 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
increases expression |
EXP |
N'-nitrosonornicotine results in increased expression of PLA2G4A mRNA |
CTD |
PMID:24835565 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions increases expression increases activity |
ISO |
Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased activity of STAT1 protein]; Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased activity of STAT1 protein]; Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of STAT1 mRNA] |
CTD |
PMID:16582591 PMID:16835749 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation |
ISO |
UGT1A4 protein results in increased glucuronidation of N'-nitrosonornicotine |
CTD |
PMID:18238858 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|